Skip to content
2000
Volume 13, Issue 4
  • ISSN: 2211-7385
  • E-ISSN: 2211-7393

Abstract

Ethosome offers a unique solution to the challenges faced by conventional drug delivery systems. In comparison to traditional liposomes and other nanocarriers, ethosomes exhibit a unique ability to improve drug absorption, overcoming a major limitation in the Transdermal Drug Delivery System. Their soft and flexible nano-vesicular structure facilitates faster permeation, resulting in significantly higher transdermal flux. This scientific investigation effectively traverses the changing landscape of ethosomes as an innovative drug delivery system. By conducting a thorough comparative analysis, we uncover the distinct characteristics that set them apart from other nanocarriers, offering insights into their distinct advantages. The study also includes a detailed analysis of the variables that have a complex impact on performance, elucidating transport mechanisms and addressing advanced facets pivotal for refined drug delivery strategies. This comprehensive overview highlights ethosomes as a future of medicine, offering a promising future for the safe and effective treatment of diverse diseases, impacting numerous lives.

Loading

Article metrics loading...

/content/journals/pnt/10.2174/0122117385303596240513053014
2024-05-28
2025-09-03
Loading full text...

Full text loading...

References

  1. ChauhanN. VasavaP. KhanS.L. Ethosomes: Anovel drug carrier.Ann. Med. Surg.20228210459510.1016/j.amsu.2022.104595 36124209
    [Google Scholar]
  2. PatrekarP.V. InamdarS.J. MaliS.S. MujibM.T. AhirA.A. HosmaniA.H. Ethosomes as novel drug delivery system: Areview.Pharma Innov.201549, Part A10
    [Google Scholar]
  3. ChauhanAS PandeyGK JoshiA DubeyBK JainP A review on Ethosome: Anovel drug delivery system for topical fungal disease. pharma innov j201871235562
    [Google Scholar]
  4. GrossiL.N. BrazW.R. da SilvaN.P. Ethosomes as a delivery system for treatment of melanoma: Amini-review.Oncology2023255455459
    [Google Scholar]
  5. MonishaC. GaneshG. MythiliL. RadhakrishnanK. A review on ethosomes for transdermal application.Res J Pharm Technol20191273133314310.5958/0974‑360X.2019.00529.8
    [Google Scholar]
  6. AnithaP RamkanthS SankariKU Ethosomes : Anoninvasive vesicular carrier for transdermal drug delivery. Int j rev life sci201120111
    [Google Scholar]
  7. NandureHP PuranikP GiramP LoneV Ethosome: Anovel drug carrier. Int j pharmac res all sci201323612
    [Google Scholar]
  8. RajenderM Ethosomes as novel drug delivery carriers : Areview. Indo AmJ P Sci2016312
    [Google Scholar]
  9. LiuX. LiuH. LiuJ. Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo.Int. J. Nanomedicine2011624124710.2147/IJN.S16044 21499422
    [Google Scholar]
  10. MehetreN.M. SinghI. Therapeutic carriers for the vaginal delivery of anti-hiv drug.Int. J. Pharm. Sci. Res.202216254355810.13040/IJPSR.09758232.13(2).543‑58
    [Google Scholar]
  11. SatyamG. ShivaniS. GarimaG. Ethosomes: Anovel tool for drug delivery through the skin.J. Pharm. Res.201034688691
    [Google Scholar]
  12. RadaS.K. YadavS. Ethosomes: Anovel approach in vesicular drug delivery systems.J. Pharm. Res. Int.20223428B627110.9734/jpri/2022/v34i28B36036
    [Google Scholar]
  13. RamakrishnaGA ManobarSD BhanudasSR Ethosomes: carrier for enhanced transdermal drug delivery system. circulation201412
    [Google Scholar]
  14. GargV. SinghH. BimbrawhS. Ethosomes and transfersomes: Principles, perspectives and practices.Curr. Drug Deliv.2017145613633 27199229
    [Google Scholar]
  15. SavoireR. Subra-PaternaultP. BardeauT. MorvanE. GrélardA. CansellM. Selective extraction of phospholipids from food by-products by supercritical carbon dioxide and ethanol and formulating ability of extracts.Separ. Purif. Tech.202023811639410.1016/j.seppur.2019.116394
    [Google Scholar]
  16. EspositoE. DrechslerM. NastruzziC. CortesiR. Cubic phases, cubosomes and ethosomes for cutaneous application.Curr. Pharm. Des.201622355382539910.2174/1381612822666160726123227 27839503
    [Google Scholar]
  17. AinbinderD. PaolinoD. FrestaM. TouitouE. Drug delivery applications with ethosomes.J. Biomed. Nanotechnol.20106555856810.1166/jbn.2010.1152 21329048
    [Google Scholar]
  18. TouitouE. DayanN. BergelsonL. GodinB. EliazM. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.J. Control. Release200065340341810.1016/S0168‑3659(99)00222‑9 10699298
    [Google Scholar]
  19. SudhakarK. Ultraflexible liposome nanocargo as a dermal and transdermal drug delivery system. Nanomaterials202111.102557
    [Google Scholar]
  20. MozafariM.R. Liposomes: An overview of manufacturing techniques.Cell. Mol. Biol. Lett.2005104711719 16341279
    [Google Scholar]
  21. SinghN. GautamS.P. KumariN. KaurR. KaurM. Virosomes as novel drug delivery system: An overview.PharmaTutor2017594755
    [Google Scholar]
  22. Rossier-MirandaF.J. SchroënC.G.P.H. BoomR.M. Colloidosomes: Versatile microcapsules in perspective.Colloids Surf. A Physicochem. Eng. Asp.20093431-3434910.1016/j.colsurfa.2009.01.027
    [Google Scholar]
  23. Shahabade GururajS. Bhosale AshokV. Mutha SwatiS. An overview on nanocarrier technology-Aquasomes.J. Pharm. Res.20092711741177
    [Google Scholar]
  24. WakaskarR.R. General overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.J. Drug Target.201826431131810.1080/1061186X.2017.1367006 28797169
    [Google Scholar]
  25. BharatiaR. KumarS. ChaursiyaS. GautamK.M. BhartiS. VarunR. Sphingosomes: Anovel vesicular drug delivery system.Int J Pharma ProfessRes2023143889310.48165/ijppronline.2023.14308
    [Google Scholar]
  26. Al-kafAG OthmanAM Pharmacosomes: An updated review. Univ j pharmac res2017213033
    [Google Scholar]
  27. DubeyV. MishraD. JainN.K. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery.Eur. J. Pharm. Biopharm.200767239840510.1016/j.ejpb.2007.03.007 17452098
    [Google Scholar]
  28. MostafaD.A. HashadA.M. AbdelreheemA.Y. A novel vesicular lipid carrier systems to enhance acyclovir delivery through skin.Int J Pharm Res Allied Sci20187209
    [Google Scholar]
  29. ChenJ.G. JiangY. YangZ.B. Preparation of triptolide ethosomes.Afr. J. Pharm. Pharmacol.20126139981004
    [Google Scholar]
  30. PandeyV. GolhaniD. ShuklaR. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents.Drug Deliv.2015228988100210.3109/10717544.2014.889777 24580572
    [Google Scholar]
  31. DavidS.R. HuiM.S. PinC.F. CiF.Y. RajabalayaR. Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin.Int. J. Drug Deliv.20135128
    [Google Scholar]
  32. Jin-guangC.H.E.N. Preparation of curcumin ethosomes.Afr. J. Pharm. Pharmacol.20137312246225110.5897/AJPP12.435
    [Google Scholar]
  33. BodadeS.S. ShaikhK.S. KambleM.S. ChaudhariP.D. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug.Drug Deliv.2013201404610.3109/10717544.2012.752420 23311652
    [Google Scholar]
  34. JainS. UmamaheshwariR.B. BhadraD. JainN.K. Ethosomes: Anovel vesicular carrier for enhanced transdermal delivery of an antiHIV agent.Indian J. Pharm. Sci.20046617281
    [Google Scholar]
  35. DaveV. SohgauraA. TakK. Ethosomal polymeric patch containing losartan potassium for the treatment of hypertension: in-vitro and in-vivo evaluation.Biomed. Phys. Eng. Express20195606502910.1088/2057‑1976/ab4fa4
    [Google Scholar]
  36. WongW.F. AngK.P. SethiG. LooiC.Y. Recent advancement of medical patch for transdermal drug delivery.Medicina)202359477810.3390/medicina59040778 37109736
    [Google Scholar]
  37. SinkoS. AljuhaniA. EhtezaziT. Ethosomal nanocarriers for the topical delivery of flurbiprofen: Physicochemical characterization and in vitro permeation studies.J. Drug Deliv. Sci. Technol.2021112104024
    [Google Scholar]
  38. JainS. PatelN. MadanP. LinS. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.Pharm. Dev. Technol.201520447348910.3109/10837450.2014.882939 24490793
    [Google Scholar]
  39. GadS. mousa, Hamadi T, sayed O. An evaluation of the effects of ethosomes in the delivery of transdermal drugs.Rec Pharmac Biomed Sci20226312012710.21608/rpbs.2022.141371.1147
    [Google Scholar]
  40. GuptaA. Acyclovir Ethosomes Design, Characterization And Release Study.
    [Google Scholar]
  41. TouitouE. GodinB. Ethosomes for skin delivery.J. Drug Deliv. Sci. Technol.200717530330810.1016/S1773‑2247(07)50046‑8
    [Google Scholar]
  42. EspositoE. CalderanL. GalvanA. Ex Vivo evaluation of ethosomes and transethosomes applied on human skin: A comparative study.Int. J. Mol. Sci.202223231511210.3390/ijms232315112 36499432
    [Google Scholar]
  43. OpathaS.A.T. TitapiwatanakunV. ChutoprapatR. Transfersomes: Apromising nanoencapsulation technique for transdermal drug delivery.Pharmaceutics202012985510.3390/pharmaceutics12090855 32916782
    [Google Scholar]
  44. AbdulbaqiI.M. DarwisY. KhanN.A. AssiR.A. KhanA.A. Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.Int. J. Nanomedicine2016112279230410.2147/IJN.S105016 27307730
    [Google Scholar]
  45. PatwekarS.L. KhavaneK.B. ChainpureP.R. ShivpujeS.A. A review on different preparation methods used for development of curcumin nanoparticles.Int J Creat ResThoug20219140884101
    [Google Scholar]
  46. SuzukiK. TanakaN. AndoA. TakagiH. Optical properties and fabrication of cuprous oxide nanoparticles by microemulsion method.J. Am. Ceram. Soc.20119482379238510.1111/j.1551‑2916.2011.04413.x
    [Google Scholar]
  47. JantrawutP. BoonsermsukcharoenK. ThipnanK. ChaiwaritT. HwangK.M. ParkE.S. Enhancement of antibacterial activity of orange oil in pectin thin film by microemulsion.Nanomaterials20188754510.3390/nano8070545 30029478
    [Google Scholar]
  48. MohammedM.I. MakkyA.M. AbdellatifM.M. Formulation and characterization of ethosomes bearing vancomycin hydrochloride for transdermal delivery.Int. J. Pharm. Pharm. Sci.2014190194
    [Google Scholar]
  49. ZhaiY. XuR. WangY. LiuJ. WangZ. ZhaiG. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties.J. Liposome Res.201525431632410.3109/08982104.2014.999686 25625544
    [Google Scholar]
  50. ManikkathJ. HegdeA.R. ParekhH.S. MutalikS. Peptide dendrimers in delivery of bioactive molecules to skin.Nanosci Dermatol2016899710.1016/B978‑0‑12‑802926‑8.00007‑0
    [Google Scholar]
  51. ZahidS.R. UpmanyuN. DangiS. RayS.K. JainP. ParkheG. Ethosome: Anovel vesicular carrier for transdermal drug delivery.J. Drug Deliv. Ther.20188631832610.22270/jddt.v8i6.2028
    [Google Scholar]
  52. PrausnitzM.R. LangerR. Transdermal drug delivery.Nat. Biotechnol.200826111261126810.1038/nbt.1504 18997767
    [Google Scholar]
  53. JaiswalP.K. KesharwaniS. KesharwaniR. PatelD.K. Ethosome: Anew technology used as topical & transdermal delivery system.J. Drug Deliv. Ther.20166371710.22270/jddt.v6i3.1245
    [Google Scholar]
  54. ZahidA.A. ChakrabortyA. LuoW. CoyleA. PaulA. Tailoring the inherent properties of biobased nanoparticles for nanomedicine.ACS Biomater. Sci. Eng.2023973972398610.1021/acsbiomaterials.3c00364 37378614
    [Google Scholar]
  55. AhadA. AkhtarN. GuptaD.K. Ethosomes: Apotential vesicular carrier for drug delivery.In: Systems of Nanovesicular Drug Delivery.Academic Press202222123710.1016/B978‑0‑323‑91864‑0.00003‑6
    [Google Scholar]
  56. AliS ShabbirM ShahidN The structure of skin and transdermal drug delivery system: A review. Res j pharm technol201582103910.5958/0974‑360X.2015.00019.0
    [Google Scholar]
  57. MeesaR. SrinivasA. ChandrasekharK.B. Design and characterization of delavirdine ethosomal drug delivery to enhance the bioavailability via topical drug delivery.Int. J. Health Sci.2022II111781119710.53730/ijhs.v6nS2.8015
    [Google Scholar]
  58. RaoB.N. ReddyK.R. MounikaB. FathimaS.R. TejaswiniA. Vesicular drug delivery system: Areview.Int. J. Chemtech Res.2019125395310.20902/IJCTR.2019.120505
    [Google Scholar]
  59. KambojS SainiV MagonN BalaS JhawatV Vesicular drug delivery systems: A novel approach for drug targeting. brain201311118
    [Google Scholar]
  60. WahidA.A. RavouruN. LakshmanS.R. Ethosomes: Atool for transdermal drug delivery.Curr. Trends Biotechnol. Pharm.201151972981
    [Google Scholar]
  61. NainwalN. JawlaS. SinghR. SaharanV.A. Transdermal applications of ethosomes a detailed review.J. Liposome Res.201929210311310.1080/08982104.2018.1517160 30156120
    [Google Scholar]
  62. LuJ. GuoT. FanY. Recent developments in the principles, modification and application prospects of functionalized ethosomes for topical delivery.Curr. Drug Deliv.202118557058210.2174/1567201817666200826093102 32851961
    [Google Scholar]
  63. PaliwalS. TilakA. SharmaJ. Flurbiprofen loaded ethosomes transdermal delivery of anti-inflammatory effect in rat model.Lipids Health Dis.201918113310.1186/s12944‑019‑1064‑x 30611256
    [Google Scholar]
  64. MauryaS.D. PrajapatiS. GuptaA. SaxenaG. DhakarR.C. Formulation development and evaluation of ethosome of stavudine.Int J Pharm Edu Res20101316
    [Google Scholar]
  65. SguizzatoM. FerraraF. HallanS.S. Ethosomes and transethosomes for mangiferin transdermal delivery.Antioxidants202110576810.3390/antiox10050768 34066018
    [Google Scholar]
  66. LimsuwanT. BoonmeP. KhongkowP. AmnuaikitT. Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications.BioMed Res. Int.2017201711210.1155/2017/8310979 28804723
    [Google Scholar]
  67. MousaI.A. HammadyT.M. GadS. ZaitoneS.A. El-SherbinyM. SayedO.M. Formulation and characterization of metformin-loaded ethosomes for topical application to experimentally induced skin cancer in mice.Pharmaceuticals202215665710.3390/ph15060657 35745575
    [Google Scholar]
  68. RamtekeS. BarupalA.K. GuptaV. Preparation and characterization of ethosomes for topical delivery of aceclofenac.Indian J. Pharm. Sci.201072558258610.4103/0250‑474X.78524 21694989
    [Google Scholar]
  69. JainS. TiwaryA.K. SapraB. JainN.K. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.AAPS PharmSciTech20078424910.1208/pt0804111 18181532
    [Google Scholar]
  70. SicurellaM. PulaW. MusiałK. Ethosomal gel for topical administration of dimethyl fumarate in the treatment of HSV-1 infections.Int. J. Mol. Sci.2023244413310.3390/ijms24044133 36835541
    [Google Scholar]
  71. GuptaN.B. LoonaS. KhanM.U. Ethosomes as elastic vesicles in transdermal drug delivery: An overview.Int. J. Pharm. Sci. Res.201233682
    [Google Scholar]
  72. RathoreG.S. TanwarY.S. SharmaA. Fluconazole loaded ethosomes gel and liposomes gel: an updated review for the treatment of deep fungal skin infection.Pharm. Chem. J.2015214150
    [Google Scholar]
  73. GodinB. TouitouE. Ethosomes: new prospects in transdermal delivery.Crit. Rev. Ther. Drug Carrier Syst.2003202-315321410.1615/CritRevTherDrugCarrierSyst.v20.i1.20
    [Google Scholar]
  74. ChandraA. AggarwalG. ManchandaS. NarulaA. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis.Pharm. Nanotechnol.20197536237410.2174/2211738507666190906123643 31490769
    [Google Scholar]
  75. SarafS. Kumar GuptaM. Itraconazole loaded ethosomal gel system for efficient treatment of skin cancer.Int. J. Drug Deliv.2018101121910.5138/09750215.2246
    [Google Scholar]
  76. NairR.S. BillaN. LeongC.O. MorrisA.P. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M ® membrane and excised human skin.Pharm. Dev. Technol.202126224325110.1080/10837450.2020.1860087 33274672
    [Google Scholar]
  77. FerraraF. BenedusiM. SguizzatoM. Ethosomes and transethosomes as cutaneous delivery systems for quercetin: A preliminary study on melanoma cells.Pharmaceutics2022145103810.3390/pharmaceutics14051038 35631628
    [Google Scholar]
  78. AbubakrA.H. IbrahemA.E. SalahM. Ethosomes: A potential nanocarrier for transdermal drug delivery‏.ERU Res J202321161176
    [Google Scholar]
  79. VermaP. PathakK. Therapeutic and cosmeceutical potential of ethosomes: An overview.J. Adv. Pharm. Technol. Res.20101327428210.4103/0110‑5558.72415 22247858
    [Google Scholar]
  80. WahyuningtyasR. KurniawatiE.M. UtomoB. License. Available from: http://creativecommons. org/licenses/by/4.0/ which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
  81. Xiao-FeiL.I.A.N.G. Jing-YingH.U. Fu-HuaC.H.E.N. Zong-HaiL.I. JinC.H.A.N.G. Characterization of chitosan polymeric ethosomes capable of encapsulating hydrophobic and hydrophilic drugs prepared by a microemulsion method.Wuli Huaxue Xuebao201228489790210.3866/PKU.WHXB201202091
    [Google Scholar]
  82. MadhaviB.B. VennelaK.S. MasanaP. MadipojuB. Enhanced transdermal drug penetration of curcumin via ethosomes.Malays. J. Pharm. Sci.201311149
    [Google Scholar]
  83. WenfengD PengY ZhangC Ceramide ethosome and preparation method and application thereof. Patent CN115919680A2022
    [Google Scholar]
  84. HengLI JianxinXU Composite volatile oil ethosome and preparation method thereof. Patent CN115843864A2022
    [Google Scholar]
  85. NanaY. Tropisetron hydrochloride ethosome gel plaster and preparation method thereof. Patent CN114617859A2022
    [Google Scholar]
  86. AhmedT.A. AlzahraniM.M. AlhakamyN.A. FelimbanR.I. Inventors; King Abdulaziz University, assignee. Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles. patent US11285148,2022
    [Google Scholar]
  87. YongtaiZ NiapingF HongyuZ ZhiW TengG XiaolinH Hyaluronic acid modified ethosome, acupoint drug delivery system containing same and application of system. Patent CN114288248A,2021
    [Google Scholar]
  88. KimY.M. JangG.H. Inventors; Binotec Co Ltd, assignee. Method of preparing bioactive substance-encapsulated ethosome, ethosome composition and cosmetic composition including ethosome composition. patent US11452679,2022
    [Google Scholar]
  89. HoKJ YongJJ Ethosomal composition including ethosomes encapsulating vitamin and dexpanthenol and method for preparing the same. Patent AU2020389480A12020
    [Google Scholar]
  90. ShenquanL MingfeiS NanshanQI Selamectin ethosome preparation and preparation method and application thereof. Patent CN110680803A12019
    [Google Scholar]
  91. LinG FuX WangH. Thymosin beta-4 ethosome and preparation process thereof. Patent CN108721604B2018
    [Google Scholar]
  92. DuQ ChenQ JinP Antioxidant nanometer ethosome rose essence and preparation method thereof. Patent CN106880505B2017
    [Google Scholar]
  93. QizhenDU YuanyuanY WeihuaZ QingC Release controlled nanometer ethosome essence and preparation method thereof. Patent CN106753789B2016
    [Google Scholar]
  94. KlokkersK. A kind of tetracaine ethosome and its preparation technology. Patent CN106474065A2016
  95. WangH YangX LinSI YuF ChenM FanL Preparation method of ethosome/natural material/polyvinyl alcohol composite hydrogel. Patent CN104706571A2015
    [Google Scholar]
  96. JieC ChangpingH MaoxinZ KaipinN Ethosome gel filmcoating agent with multiple wound repair effects and preparation method of ethosome gel film-coating agent. Patent CN103893394A2014
    [Google Scholar]
  97. PingB RongH LinC RongW HuanhuanW XiaoliH Chinese medicinal ethosome gel patch for treating herpes zoster and preparation method thereof. Patent CN103536700A2014
    [Google Scholar]
  98. XianyingZ YongpingS JiningG YiminL HuawenZ XiangX Lidocaine ethosome and preparation method thereof. Patent CN102813624A2012
    [Google Scholar]
  99. ZhangS DengH LinH ZhangX Progesterone ethosome and preparation method and application thereof. Patent CN102397255A2012
    [Google Scholar]
  100. NianpingYY JihuiZ HaitingW XiaoqinS Podophyllotoxin ethosomes and preparation methods thereof. Patent CN102144972A2010
    [Google Scholar]
  101. WadherK. PounikarS.D. TrivediS. UmekarM. Ethosome: A novel vesicular carrier.Int J Innov Res Adv Stud201851320
    [Google Scholar]
  102. FaustinoC. PinheiroL. Lipid systems for the delivery of amphotericin b in antifungal therapy.Pharmaceutics20201212910.3390/pharmaceutics12010029 31906268
    [Google Scholar]
  103. KolimiP. Innovative treatment strategies to accelerate wound healing: trajectory and recent advancements. Cells202211.152439
    [Google Scholar]
  104. Google ParentsAvailable from: https://patents.google.com/ (accessed Dec 07, 2023)
  105. AhmedS. Sarim ImamS. ZafarA. AliA. AqilM. GullA. in vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic.Artif. Cells Nanomed. Biotechnol.20164481793180210.3109/21691401.2015.1102742 26584819
    [Google Scholar]
  106. AkhtarN. PathakK. Preclinical and clinical aspects of antimicrobial drugs delivered through ethosomal vesicles.Antiinfect. Agents20121011525
    [Google Scholar]
  107. CostanzoM. Formulative study and intracellular fate evaluation of ethosomes and transethosomes for vitamin D3 delivery. Int j molec sci 202122.105341
    [Google Scholar]
  108. AhadA. AqilM. KohliK. SultanaY. MujeebM. Nano vesicular lipid carriers of angiotensin II receptor blocker: Anti-hypertensive and skin toxicity study in focus.Artif. Cells Nanomed. Biotechnol.201644310021007 25707444
    [Google Scholar]
  109. AlshehriS. HussainA. AltamimiM.A. RamzanM. in vitro, ex vivo, and in vivo studies of binary ethosomes for transdermal delivery of acyclovir: Acomparative assessment.J. Drug Deliv. Sci. Technol.20216210239010.1016/j.jddst.2021.102390
    [Google Scholar]
  110. ShakibaieM. ShahverdiA.R. FaramarziM.A. HassanzadehG.R. RahimiH.R. SabzevariO. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice.Pharm. Biol.2013511586310.3109/13880209.2012.710241 23035822
    [Google Scholar]
  111. SantosA.C. MoraisF. SimõesA. Nanotechnology for the development of new cosmetic formulations.Expert Opin. Drug Deliv.201916431333010.1080/17425247.2019.1585426 30793641
    [Google Scholar]
  112. SalemH.F. KharshoumR.M. Abou-TalebH.A. AbouTalebH.A. AbouElhassanK.M. Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome.J. Liposome Res.201929218319410.1080/08982104.2018.1524483 30221566
    [Google Scholar]
  113. Paiva-SantosA.C. SilvaA.L. GuerraC. Ethosomes as nanocarriers for the development of skin delivery formulations.Pharm. Res.202138694797010.1007/s11095‑021‑03053‑5 34036520
    [Google Scholar]
  114. BellefroidC. LechanteurA. EvrardB. MottetD. Debacq-ChainiauxF. PielG. in vitro skin penetration enhancement techniques: Acombined approach of ethosomes and microneedles.Int. J. Pharm.201957211879310.1016/j.ijpharm.2019.118793 31715350
    [Google Scholar]
  115. DevakiJ. PavuluriS. SumaN. Ethosomes: A vesicular carrier as a novel tool for transdermal drug delivery system.J. Drug Deliv. Ther.202313415916410.22270/jddt.v13i4.5796
    [Google Scholar]
  116. MalikM.A. WaniM.Y. HashimM.A. Microemulsion method: Anovel route to synthesize organic and inorganic nanomaterials.Arab. J. Chem.20125439741710.1016/j.arabjc.2010.09.027
    [Google Scholar]
  117. UrbaniakT. MusiałW. Influence of solvent evaporation technique parameters on diameter of submicron lamivudine-poly-ε-caprolactone conjugate particles.Nanomaterials201999124010.3390/nano9091240 31480469
    [Google Scholar]
  118. SchultzS. WagnerG. UrbanK. UlrichJ. High‐pressure homogenization as a process for emulsion formation.Ind ChemPlant EquipProc EngBiotechno2004274361368
    [Google Scholar]
  119. KhanM.S. MohapatraS. GuptaV. Potential of lipid-based nanocarriers against two major barriers to drug delivery skin and blood brain barrier.Membranes202313334310.3390/membranes13030343 36984730
    [Google Scholar]
  120. Valsalan SobaS. BabuM. PanonnummalR. Ethosomal gel formulation of alpha phellandrene for the transdermal delivery in gout.Adv. Pharm. Bull.202011113714910.34172/apb.2021.015 33747861
    [Google Scholar]
  121. ZhaoC. QuanP. LiuC. LiQ. FangL. Effect of isopropyl myristate on the viscoelasticity and drug release of a drug-in-adhesive transdermal patch containing blonanserin.Acta Pharm. Sin. B20166662362810.1016/j.apsb.2016.05.012 27818930
    [Google Scholar]
  122. HmingthansangaV. SinghN. BanerjeeS. ManickamS. VelayuthamR. NatesanS. Improved topical drug delivery: Role of permeation enhancers and advanced approaches.Pharmaceutics20221412281810.3390/pharmaceutics14122818 36559311
    [Google Scholar]
  123. SomI. BhatiaK. YasirM. Status of surfactants as penetration enhancers in transdermal drug delivery.J. Pharm. Bioallied Sci.2012412910.4103/0975‑7406.92724 22368393
    [Google Scholar]
  124. CuY. SaltzmanW.M. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.Mol. Pharm.20096117318110.1021/mp8001254 19053536
    [Google Scholar]
  125. NosovaA.S. KoloskovaO.O. NikonovaA.A. Diversity of PEGylation methods of liposomes and their influence on RNA delivery.MedChemComm201910336937710.1039/C8MD00515J 31015904
    [Google Scholar]
  126. EmamS.E. ElsadekN.E. ShimizuT. IshidaT. The post-insertion method for the preparation of PEGylated liposomes. In: Liposomes: Methods and Protocols.New York, NYSpringer202315917210.1007/978‑1‑0716‑2954‑3_14
    [Google Scholar]
  127. Abreu-RejónA.D. Herrera-KaoW.A. May-PatA. Influence of molecular weight and grafting density of PEG on the surface properties of polyurethanes and their effect on the viability and morphology of fibroblasts and osteoblasts.Polymers20221422491210.3390/polym14224912 36433040
    [Google Scholar]
/content/journals/pnt/10.2174/0122117385303596240513053014
Loading
/content/journals/pnt/10.2174/0122117385303596240513053014
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): drug delivery system; Ethosomes; nanocarrier; phospholipid; stratum corneum; vesicles
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test